Hyperglycemia is the most prevalent characteristic of diabetes and plays a central role in mediating adverse effects on vascular cells during the progression of diabetic vascular complications. In diabetic microangiopathy, hyperglycemia induces biochemical and molecular changes in microvascular cells that ultimately progress to retinal, renal, and neural complications and extends to other complications, including advanced periodontal disease. In this review, we describe changes involving basement membrane thickening, tissue remodeling, gap junctions, inflammation, cytokines, and transcription factors, and their effects on the pathogenesis of diabetic microvascular complications. The majority of the changes described relate to retinal microangiopathy, since ultrastructural, structural, and biochemical alterations have been well-characterized in this tissue.
Get full access to this article
View all access options for this article.
References
1.
Abdullah KM, Luthra G, Bilski JJ, Abdullah SA, Reynolds LP, Redmer DA, et al. -1999-. Cell-to-cell communication and expression of gap junctional proteins in human diabetic and nondiabetic skin fibroblasts: effects of basic fibroblast growth factor. Endocrine10:35–41.
2.
Abu el-Asrar AM, Soliman RT, al-Amro SA, al-Shammary FJ -1995-. Production of superoxide anion by polymorphonuclear leukocytes from diabetic patients with or without diabetic retinopathy. Doc Ophthalmol91:243–254.
3.
Aikawa R, Nawano M, Gu Y, Katagiri H, Asano T, Zhu W, et al. -2000-. Insulin prevents cardiomyocytes from oxidative stress-induced apoptosis through activation of PI3 kinase/Akt. Circulation102:2873–2879.
4.
Al-Mashat HA, Kandru S, Liu R, Behl Y, Desta T, Graves DT -2006-. Diabetes enhances mRNA levels of proapoptotic genes and caspase activity, which contribute to impaired healing. Diabetes55:487–495.
5.
Barber AJ, Lieth E, Khin SA, Antonetti DA, Buchanan AG, Gardner TW -1998-. Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin. J Clin Invest102:783–791.
6.
Barber EM, Fazzari M, Pollard JW -2005-. Th1 cytokines are essential for placental immunity to Listeria monocytogenes. Infect Immun73:6322–6331.
7.
Baumgartner-Parzer SM, Wagner L, Pettermann M, Grillari J, Gessl A, Waldhausl W -1995-. High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes44:1323–1327.
8.
Bavamian S, Klee P, Britan A, Populaire C, Caille D, Cancela J, et al. -2007-. Islet-cell-to-cell communication as basis for normal insulin secretion. Diabetes Obes Metab9-Suppl 2-:118–132.
9.
Behl Y, Krothapalli P, Desta T, DiPiazza A, Roy S, Graves DT -2008-. Diabetes-enhanced tumor necrosis factor-alpha production promotes apoptosis and the loss of retinal microvascular cells in type 1 and type 2 models of diabetic retinopathy. Am J Pathol172:1411–1418.
10.
Behl Y, Krothapalli P, Desta T, Roy S, Graves DT -2009-. FOXO1 plays an important role in enhanced microvascular cell apoptosis and microvascular cell loss in type 1 and type 2 diabetic rats. Diabetes58:917–925.
11.
Black E, Vibe-Petersen J, Jorgensen LN, Madsen AM, Agren MS, Holstein PE, et al. -2003-. Decrease of collagen deposition in wound repair in type 1 diabetes independent of glycemic control. Arch Surg138:34–40.
12.
Bobbie M, Roy S, Trudeau K, Mungeroy S, Simon A, Roy S. Reduced connexin 43 expression and its effect on the development of vascular lesions in retinas of diabetic mice. -In press, 2010, Invest Ophthalmol Vis Sci-.
13.
Boengler K, Dodoni G, Rodriguez-Sinovas A, Cabestrero A, Ruiz-Meana M, Gres P, et al. -2005-. Connexin 43 in cardiomyocyte mitochondria and its increase by ischemic preconditioning. Cardiovasc Res67:234–244.
14.
Boengler K, Schulz R, Heusch G -2006-. Connexin 43 signalling and cardioprotection. Heart92:1724–1727.
15.
Brandner JM, Zacheja S, Houdek P, Moll I, Lobmann R -2008-. Expression of matrix metalloproteinases, cytokines, and connexins in diabetic and nondiabetic human keratinocytes before and after transplantation into an ex vivo wound-healing model. Diabetes Care31:114–120.
16.
Brem H, Tomic-Canic M -2007-. Cellular and molecular basis of wound healing in diabetes. J Clin Invest117:1219–1222.
17.
Brink PR, Valiunas V, Wang HZ, Zhao W, Davies K, Christ GJ -2006-. Experimental diabetes alters connexin43 derived gap junction permeability in short-term cultures of rat corporeal vascular smooth muscle cells. J Urol175:381–386.
18.
Brownlee M -2001-. Biochemistry and molecular cell biology of diabetic complications. Nature414:813–820.
19.
Bucala R, Tracey KJ, Cerami A -1991-. Advanced glycosylation products quench nitric oxide and mediate defective endothelium-dependent vasodilatation in experimental diabetes. J Clin Invest87:432–438.
20.
Burg MA, Halfter W, Cole GJ -1995-. Analysis of proteoglycan expression in developing chicken brain: characterization of a heparan sulfate proteoglycan that interacts with the neural cell adhesion molecule. J Neurosci Res41:49–64.
21.
Burrow JW, Koch JA, Chuang HH, Zhong W, Dean DD, Sylvia VL -2007-. Nitric oxide donors selectively reduce the expression of matrix metalloproteinases-8 and -9 by human diabetic skin fibro-blasts. J Surg Res140:90–98.
22.
Cagliero E, Roth T, Roy S, Lorenzi M -1991-. Characteristics and mechanisms of high-glucose-induced overexpression of basement membrane components in cultured human endothelial cells. Diabetes40:102–110.
23.
Casaroli Marano RP, Preissner KT, Vilaro S -1995-. Fibronectin, laminin, vitronectin and their receptors at newly-formed capillaries in proliferative diabetic retinopathy. Exp Eye Res60:5–17.
24.
Castellon R, Caballero S, Hamdi HK, Atilano SR, Aoki AM, Tarnuzzer RW, et al. -2002-. Effects of tenascin-C on normal and diabetic retinal endothelial cells in culture. Invest Ophthalmol Vis Sci43:2758–2766.
25.
Cherian S, Roy S, Pinheiro A, Roy S -2009-. Tight glycemic control regulates fibronectin expression and basement membrane thickening in retinal and glomerular capillaries of diabetic rats. Invest Ophthalmol Vis Sci50:943–949.
26.
Clancy RM, Leszczynska-Piziak J, Abramson SB -1992-. Nitric oxide, an endothelial cell relaxation factor, inhibits neutrophil superoxide anion production via a direct action on the NADPH oxidase. J Clin Invest90:1116–1121.
27.
Czyz J, Guan K, Zeng Q, Wobus AM -2005-. Loss of beta 1 integrin function results in upregulation of connexin expression in embryonic stem cell-derived cardiomyocytes. Int J Dev Biol49:33–41.
28.
Dagli ML, Hernandez-Blazquez FJ -2007-. Roles of gap junctions and connexins in non-neoplastic pathological processes in which cell proliferation is involved. J Membr Biol218:79–91.
29.
Das A, Frank RN, Zhang NL, Samadani E -1990a-. Increases in collagen type IV and laminin in galactose-induced retinal capillary basement membrane thickening—prevention by an aldose reductase inhibitor. Exp Eye Res50:269–280.
30.
Das A, Frank RN, Zhang NL, Turczyn TJ -1990b-. Ultrastructural localization of extracellular matrix components in human retinal vessels and Bruch’s membrane. Arch Ophthalmol108:421–429.
31.
Das A, McGuire PG, Eriqat C, Ober RR, DeJuan E Jr, Williams GA, et al. -1999-. Human diabetic neovascular membranes contain high levels of urokinase and metalloproteinase enzymes. Invest Ophthalmol Vis Sci40:809–813.
32.
Del Prete D, Anglani F, Forino M, Ceol M, Fioretto P, Nosadini R, et al. -1997-. Down-regulation of glomerular matrix metalloproteinase-2 gene in human NIDDM. Diabetologia40:1449–1454.
33.
Doganay S, Evereklioglu C, Er H, Turkoz Y, Sevinc A, Mehmet N, et al. -2002-. Comparison of serum NO, TNF-alpha, IL-1beta, sIL-2R, IL-6 and IL-8 levels with grades of retinopathy in patients with diabetes mellitus. Eye16:163–170.
34.
Du X, Stocklauser-Farber K, Rosen P -1999-. Generation of reactive oxygen intermediates, activation of NF-kappaB, and induction of apoptosis in human endothelial cells by glucose: role of nitric oxide synthase? Free Radic Biol Med27:752–763.
35.
Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al. -2002-. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation106:2067–2072.
36.
Fahey TJ 3rd, Sadaty A, Jones WG 2nd, Barber A, Smoller B, Shires GT -1991-. Diabetes impairs the late inflammatory response to wound healing. J Surg Res50:308–313.
37.
Fernandes R, Girao H, Pereira P -2004-. High glucose down-regulates inter-cellular communication in retinal endothelial cells by enhancing degradation of connexin 43 by a proteasome-dependent mechanism. J Biol Chem279:27219–27224.
38.
Ffrench-Constant C, Van de Water L, Dvorak HF, Hynes RO -1989-. Reappearance of an embryonic pattern of fibronectin splicing during wound healing in the adult rat. J Cell Biol109:903–914.
39.
Friederich M, Hansell P, Palm F -2009-. Diabetes, oxidative stress, nitric oxide and mitochondria function. Curr Diabetes Rev5:120–144.
40.
Galiano RD, Tepper OM, Pelo CR, Bhatt KA, Callaghan M, Bastidas N, et al. -2004-. Topical vascular endothelial growth factor accelerates diabetic wound healing through increased angiogenesis and by mobilizing and recruiting bone marrow-derived cells. Am J Pathol164:1935–1947.
41.
Giebel SJ, Menicucci G, McGuire PG, Das A -2005-. Matrix metalloprotein-ases in early diabetic retinopathy and their role in alteration of the blood-retinal barrier. Lab Invest85:597–607.
42.
Goubaeva F, Mikami M, Giardina S, Ding B, Abe J, Yang J -2007-. Cardiac mitochondrial connexin 43 regulates apoptosis. Biochem Biophys Res Commun352:97–103.
43.
Graves D, Cochran D -2003-. The contribution of interleukin-1 and tumor necrosis factor to periodontal tissue destruction. J Periodontol74: 391–401.
44.
Guo Y, Martinez-Williams C, Rannels DE -2002-. Integrin-mediated regulation of connexin 43 expression by alveolar epithelial cells. Chest121-3 Suppl-:30S–31S.
45.
Gyurko R, Siqueira CC, Caldon N, Gao L, Kantarci A, Van Dyke TE -2006-. Chronic hyperglycemia predisposes to exaggerated inflammatory response and leukocyte dysfunction in Akita mice. J Immunol177:7250–7256.
46.
Ha H, Lee HB -2003-. Reactive oxygen species and matrix remodeling in diabetic kidney. J Am Soc Nephrol14-8 Suppl 3-:246S–249S.
47.
Halestrap AP -2006-. Mitochondria and preconditioning: a connexin connection? Circ Res99:10–12.
48.
Hawrami K, Hitman GA, Rema M, Snehalatha C, Viswanathan M, Ramachandran A, et al. -1996-. An association in non-insulin-dependent diabetes mellitus subjects between susceptibility to retinopathy and tumor necrosis factor polymorphism. Hum Immunol46:49–54.
49.
Hayden MR, Sowers JR, Tyagi SC -2005-. The central role of vascular extracellular matrix and basement membrane remodeling in metabolic syndrome and type 2 diabetes: the matrix preloaded. Cardiovasc Diabetol4:9.
50.
He H, Liu R, Desta T, Leone C, Gerstenfeld L, Graves D -2004-. Diabetes causes decreased osteoclastogenesis, reduced bone formation, and enhanced apoptosis of osteoblastic cells in bacteria stimulated bone loss. Endocrinology145:447–452.
51.
Ho FM, Liu SH, Lin WW, Liau CS -2007-. Opposite effects of high glucose on MMP-2 and TIMP-2 in human endothelial cells. J Cell Biochem101:442–450.
52.
Inoguchi T, Yu HY, Imamura M, Kakimoto M, Kuroki T, Maruyama T, et al. -2001-. Altered gap junction activity in cardiovascular tissues of diabetes. Med Electron Microsc34:86–91.
53.
Jerdan JA, Glaser BM -1986-. Retinal microvessel extracellular matrix: an immunofluorescent study. Invest Ophthalmol Vis Sci27:194–203.
54.
Jiang ZY, Towler HMA, Luthert P, Lightman SL -1996-. Pathophysiology of diabetic retinopathy. Vol. 80. Philadelphia: Lippincott-Raven, pp. 719–727.
55.
Jin M, Kashiwagi K, Iizuka Y, Tanaka Y, Imai M, Tsukahara S -2001-. Matrix metalloproteinases in human diabetic and nondiabetic vitreous. Retina21:28–33.
56.
Joussen AM, Poulaki V, Mitsiades N, Kirchhof B, Koizumi K, Döhmen S, et al. -2002-. Nonsteroidal anti-inflammatory drugs prevent early diabetic retinopathy via TNF-alpha suppression. FASEB J16:438–440.
57.
Kayal RA, Tsatsas D, Bauer MA, Allen B, Al-Sebaei MO, Kakar S, et al. -2007-. Diminished bone formation during diabetic fracture healing is related to the premature resorption of cartilage associated with increased osteoclast activity. J Bone Miner Res22:560–568.
58.
Kelly DJ, Skinner SL, Gilbert RE, Cox AJ, Cooper ME, Wilkinson-Berka JL -2000-. Effects of endothelin or angiotensin II receptor blockade on diabetes in the transgenic -mRen-2-27 rat. Kidney Int57:1882–1894.
59.
Khan ZA, Farhangkhoee H, Mahon JL, Bere L, Gonder JR, Chan BM, et al. -2006-. Endothelins: regulators of extracellular matrix protein production in diabetes. Exp Biol Med -Maywood-231:1022–1029.
60.
Kilo C, Vogler N, Williamson J -1971-. Basement membrane thickening in diabetes. In: Diabetes mellitus: diagnosis and treatment. Vol. III. Fajans S, Sussman K, editors. New York: American Diabetes Association, Inc.
61.
Kilo C, Vogler N, Williamson JR -1972-. Muscle capillary basement membrane changes related to aging and to diabetes mellitus. Diabetes21:881–905.
62.
Kitsiou PV, Tzinia AK, Stetler-Stevenson WG, Michael AF, Fan WW, Zhou B, et al. -2003-. Glucose-induced changes in integrins and matrix-related functions in cultured human glomerular epithelial cells. Am J Physiol Renal Physiol284:F671–F679.
63.
Koevary SB, Nussey J, Lake S -2002-. Accumulation of topically applied porcine insulin in the retina and optic nerve in normal and diabetic rats. Invest Ophthalmol Vis Sci43:797–804.
64.
Kowluru RA, Abbas SN -2003-. Diabetes-induced mitochondrial dysfunction in the retina. Invest Ophthalmol Vis Sci44:5327–5334.
Kowluru RA, Kanwar M -2009-. Oxidative stress and the development of diabetic retinopathy: contributory role of matrix metalloproteinase-2. Free Radic Biol Med46:1677–1685.
67.
Kuroki T, Inoguchi T, Umeda F, Ueda F, Nawata H -1998-. High glucose induces alteration of gap junction permeability and phosphorylation of connexin-43 in cultured aortic smooth muscle cells. Diabetes47:931–936.
68.
Larson DM, Sheridan JD -1982-. Intercellular junctions and transfer of small molecules in primary vascular endothelial cultures. J Cell Biol92:183–191.
69.
Li AF, Roy S -2009-. High glucose-induced downregulation of connexin 43 expression promotes apoptosis in microvascular endothelial cells. Invest Ophthalmol Vis Sci50:1400–1407.
70.
Li AF, Sato T, Haimovici R, Okamoto T, Roy S -2003-. High glucose alters connexin 43 expression and gap junction intercellular communication activity in retinal pericytes. Invest Ophthalmol Vis Sci44:5376–5382.
71.
Li D, Ueta E, Kimura T, Yamamoto T, Osaki T -2004-. Reactive oxygen species -ROS- control the expression of Bcl-2 family proteins by regulating their phosphorylation and ubiquitination. Cancer Sci95:644–650.
72.
Li H, Tang ZH, Xia TQ -1991-. [Relationship between free radicals and diabetic microangiopathy]. Zhonghua Nei Ke Za Zhi30:402–404, 455 [article in Chinese].
73.
Limb GA, Chignell AH, Green W, LeRoy F, Dumonde DC -1996-. Distribution of TNF alpha and its reactive vascular adhesion molecules in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol80:168–173.
74.
Limb GA, Soomro H, Janikoun S, Hollifield RD, Shilling J -1999a-. Evidence for control of tumour necrosis factor-alpha -TNF-alpha- activity by TNF receptors in patients with proliferative diabetic retinopathy. Clin Exp Immunol115:409–414.
75.
Limb GA, Webster L, Soomro H, Janikoun S, Shilling J -1999b-. Platelet expression of tumour necrosis factor-alpha -TNF-alpha-, TNF receptors and intercellular adhesion molecule-1 -ICAM-1- in patients with proliferative diabetic retinopathy. Clin Exp Immunol118:213–218.
76.
Limb GA, Hickman-Casey J, Hollifield RD, Chignell AH -1999c-. Vascular adhesion molecules in vitreous from eyes with proliferative diabetic retinopathy. Invest Ophthalmol Vis Sci40:2453–2457.
McLennan SV, Kelly DJ, Schache M, Waltham W, Dy V, Langham RG, et al. -2007-. Advanced glycation end products decrease mesangial cell MMP-7: a role in matrix accumulation in diabetic nephropathy? Kidney Int72:481–488.
83.
Melman A, Christ GJ -2001-. Integrative erectile biology. The effects of age and disease on gap junctions and ion channels and their potential value to the treatment of erectile dysfunction. Urol Clin North Am28:217–231.
84.
Mizutani M, Kern TS, Lorenzi M -1996-. Accelerated death of retinal micro-vascular cells in human and experimental diabetic retinopathy. J Clin Invest97:2883–2890.
85.
Mohr S, Xi X, Tang J, Kern TS -2002-. Caspase activation in retinas of diabetic and galactosemic mice and diabetic patients. Diabetes51: 1172–1179.
86.
Nakazawa T, Chiba T, Kaneko E, Yui K, Yoshida M, Shimokado K -2005-. Insulin signaling in arteries prevents smooth muscle apoptosis. Arterioscler Thromb Vasc Biol25:760–765.
87.
Naldini A, Carraro F -2005-. Role of inflammatory mediators in angiogenesis. Curr Drug Targets Inflamm Allergy4:3–8.
88.
Nishikawa T, Edelstein D, Brownlee M -2000-. The missing link: a single unifying mechanism for diabetic complications. Kidney Int Suppl77:26–30.
89.
Nlend RN, Michon L, Bavamian S, Boucard N, Caille D, Cancela J, et al. -2006-. Connexin36 and pancreatic beta-cell functions. Arch Physiol Biochem112:74–81.
90.
Okruhlicova L, Tribulova N, Misejkova M, Kucka M, Stetka R, Slezak J, et al. -2002-. Gap junction remodelling is involved in the susceptibility of diabetic rats to hypokalemia-induced ventricular fibrillation. Acta Histochem104:387–391.
91.
Oku H, Kodama T, Sakagami K, Puro DG -2001-. Diabetes-induced disruption of gap junction pathways within the retinal microvasculature. Invest Ophthalmol Vis Sci42:1915–1920.
92.
Oshitari T, Polewski P, Chadda M, Li AF, Sato R, Roy S -2006-. Effect of combined antisense oligonucleotides against high-glucose- and diabetes-induced overexpression of extracellular matrix components and increased vascular permeability. Diabetes55:86–92.
93.
Pan HZ, Zhang L, Guo MY, Sui H, Li H, Wu WH, et al. -2009-. The oxidative stress status in diabetes mellitus and diabetic nephropathy. Acta Diabetol -in press-.
94.
Phillips AO, Morrisey K, Steadman R, Williams JD -1999-. Decreased degradation of collagen and fibronectin following exposure of proximal cells to glucose. Exp Nephrol7:449–462.
95.
Pinchback JS, Taylor BA, Gibbins JR, Hunter N -1996-. Microvascular angiopathy in advanced periodontal disease. J Pathol179:204–209.
96.
Pitre DA, Seifert JL, Bauer JA -2001-. Perineurium inflammation and altered connexin isoform expression in a rat model of diabetes related peripheral neuropathy. Neurosci Lett303:67–71.
97.
Podestá F, Roth T, Ferrara F, Cagliero E, Lorenzi M -1997-. Cytoskeletal changes induced by excess extracellular matrix impair endothelial cell replication. Diabetologia40:879–886.
98.
Podestà F, Romeo G, Liu WH, Krajewski S, Reed JC, Gerhardinger C, et al. -2000-. Bax is increased in the retina of diabetic subjects and is associated with pericyte apoptosis in vivo and in vitro. Am J Pathol156:1025–1032.
99.
Poladia DP, Schanbacher B, Wallace LJ, Bauer JA -2005-. Innervation and connexin isoform expression during diabetes-related bladder dysfunction: early structural vs. neuronal remodelling. Acta Diabetol42:147–152.
100.
Pradeep AR, Guruprasad CN, Swati P, Shikha C -2008-. Crevicular fluid endothelin-1 levels in periodontal health and disease. J Periodontal Res43:275–278.
101.
Pradham NS, White GE, Mehta N, Forgione A -2001-. Mandibular deviations in TMD and non-TMD groups related to eye dominance and head posture. J Clin Pediatr Dent25:147–155.
102.
Reiter CE, Gardner TW -2003-. Functions of insulin and insulin receptor signaling in retina: possible implications for diabetic retinopathy. Prog Retin Eye Res22:545–562.
Rodriguez-Sinovas A, Boengler K, Cabestrero A, Gres P, Morente M, Ruiz-Meana M, et al. -2006-. Translocation of connexin 43 to the inner mitochondrial membrane of cardiomyocytes through the heat shock protein 90-dependent TOM pathway and its importance for cardioprotection. Circ Res99:93–101.
105.
Rodriguez-Sinovas A, Cabestrero A, Lopez D, Torre I, Morente M, Abellan A, et al. -2007-. The modulatory effects of connexin 43 on cell death/ survival beyond cell coupling. Prog Biophys Mol Biol94:219–232.
106.
Roth T, Podesta F, Stepp MA, Boeri D, Lorenzi M -1993-. Integrin over-expression induced by high glucose and by human diabetes: potential pathway to cell dysfunction in diabetic microangiopathy. Proc Natl Acad Sci USA90:9640–9644.
107.
Roy S, Lorenzi M -1996-. Early biosynthetic changes in the diabetic-like retinopathy of galactose-fed rats. Diabetologia39:735–738.
108.
Roy S, Cagliero E, Lorenzi M -1996-. Fibronectin overexpression in retinal microvessels of patients with diabetes. Invest Ophthalmol Vis Sci37:258–266.
109.
Roy S, Sato T, Paryani G, Kao R -2003-. Downregulation of fibronectin overexpression reduces basement membrane thickening and vascular lesions in retinas of galactose-fed rats. Diabetes52:1229–1234.
110.
Salzmann J, Limb GA, Khaw PT, Gregor ZJ, Webster L, Chignell AH, Charteris DG -2000-. Matrix metalloproteinases and their natural inhibitors in fibrovascular membranes of proliferative diabetic retinopathy. Br J Ophthalmol84:1091–1096.
111.
Sandbach JM, Coscun PE, Grossniklaus HE, Kokoszka JE, Newman NJ, Wallace DC -2001-. Ocular pathology in mitochondrial superoxide dismutase -Sod2--deficient mice. Invest Ophthalmol Vis Sci42: 2173–2178.
112.
Sato T, Haimovici R, Kao R, Li AF, Roy S -2002-. Downregulation of connexin 43 expression by high glucose reduces gap junction activity in microvascular endothelial cells. Diabetes51:1565–1571.
113.
Sawai K, Mukoyama M, Mori K, Yokoi H, Koshikawa M, Yoshioka T, et al. -2006-. Redistribution of connexin43 expression in glomerular podocytes predicts poor renal prognosis in patients with type 2 diabetes and overt nephropathy. Nephrol Dial Transplant21:2472–2477.
114.
Simon AM, Goodenough DA -1998-. Diverse functions of vertebrate gap junctions. Trends Cell Biol8:477–483.
115.
Simon HU, Haj-Yehia A, Levi-Schaffer F -2000-. Role of reactive oxygen species -ROS- in apoptosis induction. Apoptosis5:415–418.
116.
Siperstein MD, Unger RH, Madison LL -1968-. Studies of muscle capillary basement membranes in normal subjects, diabetic, and prediabetic patients. J Clin Invest47:1973–1999.
117.
Sun W, Gerhardinger C, Dagher Z, Hoehn T, Lorenzi M -2005-. Aspirin at low-intermediate concentrations protects retinal vessels in experimental diabetic retinopathy through non-platelet-mediated effects. Diabetes54:3418–3426.
118.
Tanaka M, Sawada M, Yoshida S, Hanaoka F, Marunouchi T -1995-. Insulin prevents apoptosis of external granular layer neurons in rat cerebellar slice cultures. Neurosci Lett199:37–40.
119.
Taylor GW, Burt BA, Becker MP, Genco RJ, Shlossman M, Knowler WC, Pettitt DJ -1998-. Non-insulin dependent diabetes mellitus and alveolar bone loss progression over 2 years. J Periodontol69:76–83.
120.
Tesfamariam B, Cohen RA -1992-. Free radicals mediate endothelial cell dysfunction caused by elevated glucose. Am J Physiol263-2 Pt 2-:321–326.
121.
Thorstensson H, Kuylenstierna J, Hugoson A -1996-. Medical status and complications in relation to periodontal disease experience in insulin-dependent diabetics. J Clin Periodontol23-3 Pt 1-:194–202.
122.
Urbich C, Dernbach E, Rossig L, Zeiher AM, Dimmeler S -2008-. High glucose reduces cathepsin L activity and impairs invasion of circulating progenitor cells. J Mol Cell Cardiol45:429–436.
123.
van Hecke MV, Dekker JM, Nijpels G, Moll AC, Heine RJ, Bouter LM, Polak BC, Stehouwer CD -2005-. Inflammation and endothelial dysfunction are associated with retinopathy: the Hoorn Study. Diabetologia48:1300–1306.
124.
Visse R, Nagase H -2003-. Matrix metalloproteinases and tissue inhibitors of metalloproteinases: structure, function, and biochemistry. Circ Res92: 827–839.
125.
Wagner C -2008-. Function of connexins in the renal circulation. Kidney Int73:547–555.
126.
Wei CJ, Xu X, Lo CW -2004-. Connexins and cell signaling in development and disease. Annu Rev Cell Dev Biol20:811–838.
127.
Wilkins AS -1998-. Gap junction-mediated intercellular signalling in health and disease. Bioessays20:686–688.
128.
Yang R, Liu H, Williams I, Chaqour B -2007-. Matrix metalloproteinase-2 expression and apoptogenic activity in retinal pericytes: implications in diabetic retinopathy. Ann NY Acad Sci1103:196–201.
129.
Yoon S, Gingras D, Bendayan M -2001-. Alterations of vitronectin and its receptor alpha-v- integrin in the rat renal glomerular wall during diabetes. Am J Kidney Dis38:1298–1306.
130.
Zhang SX, Wang JJ, Gao G, Shao C, Mott R, Ma JX -2006-. Pigment epithelium-derived factor -PEDF- is an endogenous antiinflammatory factor. FASEB J20:323–325.
131.
Zhang X, Chen X, Wu D, Liu W, Wang J, Feng Z, et al. -2006-. Downregulation of connexin 43 expression by high glucose induces senescence in glomerular mesangial cells. J Am Soc Nephrol17:1532–1542.
